IRM
50
3
WEC
56
3
GD
42
3
PFE
26
3
GLW
48
2
ORCL
63
-2
NEE
54
4
ALL
45
-6
GOOG
55
5
IBM
61
3
HUM
43
-6
ES
38
4
KO
49
5
FSLR
49
-5
PRGO
43
4
MSI
70
-3
ZION
68
3
AN
61
3
TROW
61
5
WHR
70
6
IRM
50
3
WEC
56
3
GD
42
3
PFE
26
3
GLW
48
2
ORCL
63
-2
NEE
54
4
ALL
45
-6
GOOG
55
5
IBM
61
3
HUM
43
-6
ES
38
4
KO
49
5
FSLR
49
-5
PRGO
43
4
MSI
70
-3
ZION
68
3
AN
61
3
TROW
61
5
WHR
70
6
Financhill
Back

Viking Therapeutics 10K Form

Sell
38

VKTX
Viking Therapeutics

Last Price:
53.43
Seasonality Move:
47.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-21.96M
Price / Cash Flow: 0
Annual Sales: $8.18
Price / Book: 6.36

Profitability

EPS (TTM): -0.93000
Net Income (TTM): $-99.15M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Viking Therapeutics Earnings Forecast

Key Viking Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Viking Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Sell
38
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?